Company Overview and News

1
CLX / Clorox Company (The) 10-K (Annual Report)

2018-08-14 sec.gov
Document Table of Contents
CLX

1
I Bought Illinois Tool Works After Its Nearly 30% Dividend Increase

2018-08-09 seekingalpha
Illinois Tool Works' 28.2% dividend increase inspired me to raise my PT and finally buy shares of this Dividend Aristocrat.
ITW KO CLX

116
Tracking Yacktman Asset Management Portfolio - Q2 2018 Update

2018-08-06 seekingalpha
Yacktman Asset Management decreased Twenty-First Century Fox, Microsoft, Sysco, and Cisco Systems substantially during the quarter.
ATHTF SYY XOM ULVR AVP RDI CHRW UNLNF UHAL SYK CSCO CMCSK ABBV HSY MO CRMT FOX GLW BAC HSYFB NWS NWSA UNLYF INFY BRK.A JNJ BK INFY ABBV MSFT CLX FOXA WFCNP PG CCV CCZ BAC COP OTEL PM RDIB NWS KO ORCL DIS WFC GJV UL UN CMCSA ANTM PEP CCV.CL OCLCF ANTX

401
Stocks To Watch: Meet The New Ford

2018-08-04 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
SYY AMAL RUTH BECN QES WHR HABT VIAB STI-A TSN WING SNAP MRCY WHD JCOM NWSA GPRE CRSP MDT REV GPK ZOES VCTR MGM WSO DFRG CTB OLED RAD GMVHF TEN HMI FLBD AGN CL AAPL UCBI KO USAP CBS GJV RRGB MUSA MCHP DDD "QES" VC TSLA CAKE APTV VPG BYD ARHVF EAT XON AMRS BLMN LDOS CVS UAL AMZN AIT NDSN CABO UPS KDP AAL CARS BR STE MAR REVG STI CLX BKEP TXRH DAN PG YELP TREC CDLX STMP ANDV MAR.WI MYL TSNU NWS KWR GM DIN FRPT DIS ECL F M FDX K BMI TGT ZG BKNG EOLS THRM DPZ ORLY

5
The Clorox (CLX) Q4 2018 Results - Earnings Call Transcript

2018-08-02 seekingalpha
Good day, ladies and gentlemen, and welcome to The Clorox Company Fourth Quarter and Fiscal Year 2018 Earnings Release Conference Call. At this time, all participants are in a listen-only mode. At the conclusion of our prepared remarks, we will conduct a question-and-answer session. As a reminder, this call is being recorded.
WFC WFCNP CLX

1
CLX / Clorox Company (The) CURRENT REPORT (Current Report)

2018-08-02 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 8-K CURRENT REPORT
CLX

1
CHD, CLX Earnings on Aug 2: Here are the Key Predictions

2018-08-01 zacks
The earnings season is in full swing and the picture that has emanated so far is quite a healthy one. Per the Earnings Preview dated Jul 27, 265 of the S&P 500 members have reported results. Out of these S&P 500 companies that have reported their quarterly numbers, approximately 80.8% delivered positive earnings surprises, while 72.1% beat top-line expectations. Further, earnings for these companies have advanced 23.
CLX

4
Will Clorox (CLX) Beat Q4 Earnings Despite Margin Woes?

2018-08-01 zacks
The Clorox Company (CLX - Free Report) is slated to report fourth-quarter fiscal 2018 results on Aug 2. It delivered a positive earnings surprise of 5.4% in the last reported quarter. A glimpse of the company’s earnings performance in the trailing four quarters shows that it has outpaced estimates by an average positive surprise of 3.1%. Additionally, the company’s surprise history reveals that it has delivered an earnings beat in each of the past six quarters and topped sales estimates in three of the last four quarters.
WLK PF CLX

20
Top Analyst Upgrades and Downgrades: Alcoa, Cisco, eBay, IBM, P&G, Square, Tesla, United Continental, Visa and More

2018-07-19 247wallst
Stocks were looking for direction on Wednesday with a fairly light day on economic data. Investors have had less faith and have seen lower rewards from buying the dips than in prior years. Many of those same investors also have been concerned about how they want their investments positioned ahead of the midterm elections, into international trade concerns and for into 2019 and beyond.
BMCH ABT AAI STCK CL CSCO AEP MS ARA AA EBAY ABT IBM V TRI CLX

1
Wednesday’s Biggest Winners and Losers in the S&P 500

2018-07-18 247wallst
July 18, 2018: The S&P 500 closed up 0.2% at 2,815.63. The DJIA closed up 0.3% at 25,199.90. Separately, the Nasdaq was flat at 7,854.44.
GWW CLX

2
Dividend Champion Spotlight: The Clorox Company

2018-07-17 seekingalpha
This household name is about much more than bleach. It has also raised its dividend 41 consecutive times.
CLX

45
3 Reasons to Consider Buying Walmart Stock Right Now

2018-07-10 investorplace
Is Walmart Inc (NYSE:WMT) the top retail stock to buy? Given that WMT stock is down 14.5% this year, the answer seems like a resounding “no.” However, some are wondering if now is the time to load up on the company.
HD TGT KR AMZN T CVX M CLX WMT

1
Clorox vs. Church & Dwight Co: Which Is the Better Buy?

2018-07-06 investorplace
Only my editors might know how I’d answer this question but it’s been awhile since I’ve covered either Clorox Co (NYSE:CLX) or Church & Dwight Co. (NYSE:CHD) so before I decide if CLX stock is better than CHD stock or vice-versa, why don’t we have a look at each company’s strengths?
PG CLX CHD

93
July 2018 Stock Considerations

2018-07-02 seekingalpha
Here we are with another installment of my "stock considerations" for the upcoming month. With the first week of trading upon us in July, it is time, once again, to lay out a plan for my potential stock pick(s) for the month. As many of you already know, I make sure to purchase at least one stock every single month, no matter where we are in a business or macroeconomic cycle. The goal of every long-term dividend growth investor is to remain consistent with their buys and try not to attempt to time the market and wait for the "best" possible time to invest.
SOJA HCN PM GIS HCP LTC SBRA WELL CAH ED JCI SBRAP VTR SO GE GEC D KMB PEP KHC GNE SBUX CLX

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 189054109